In this article an infectious diseases pharmacist with over a decade of experience in the field outlines five secrets for how to run a successful antimicrobial stewardship program. Authored By: Timothy P. Gauthier, Pharm.D., BCPS, BCIDP Article Posted 12 September 2021 Since graduating from my PGY2 infectious diseases training program in 2010 I … [Read more...]

In this article the literature comparing piperacillin-tazobactam versus carbapenems for ESBL infections is provided in table format. Consideration for the strengths and limitations of existing data are discussed.  Authored By: Melissa Santibañez, Pharm.D., BCCCP;1 Andrea Duque, Pharm.D.;2 Taylor Harris, Pharm.D.3 1Assistant Professor, Nova Southeastern … [Read more...]

In this article an infectious diseases and antimicrobial stewardship pharmacist discusses five tips for developing localized antimicrobial stewardship guidelines.  Authored by: Timothy P. Gauthier, Pharm.D, BCPS, BCIDP Article Posted: 12 June 2021 Guidelines for infectious diseases are essential towards directing expected practices and good … [Read more...]

Telehealth has transformed healthcare delivery, including the care of patients with infectious diseases. It can support antimicrobial stewardship efforts and regulatory compliance. Here, three infectious diseases pharmacists weigh in on the topic and identify several things to know about tele-antimicrobial stewardship programs. Authored By: Christina … [Read more...]

In this article two pharmacists discuss what 340B means, providing perspectives and insights on this special program. A discussion between Joe Osborne, Pharm.D. & Christina Rivera, PharmD, BCPS, AAHIV-M Article Posted 25 April 2021 The 340B program often prompts confusion in healthcare professionals given the labyrinth of terminology and the … [Read more...]